| |
Functional remission of HBeAg negative chronic HBV infection after withdrawal of combined therapy with REP 2139 or REP 2165, TDF and peg-IFN
|
| |
| |
Reported by Jules Levin
AASLD Industry Colloquium
Jan 19-20, 2018, Bethesda, MD, USA
M. Bazinet1, V. Pantea2, G. Placinta2, I. Moscalu3, V. Cebotarescu2, L. Cojuhari2, P. Jimbei4, L. Iarovoi2, V. Smesnoi4, T. Musteata4, A. Jucov2,3, A. Krawczyk5A. Vaillant1
1. Replicor Inc. Montreal, Canada
2. Departmentof Infectious Diseases, Nicolae TestemitanuState Universityof Medicineand Pharmacy, Chisinau, Republicof Moldova
3. ARENSIA ExploratoryMedicine, Republican Clinical Hospital, Chisinau, Republicof Moldova
4. Toma CiorbaInfectious Clinical Hospital, Chisinau, Republicof Moldova.
5. UniversitatsklinikumEssen, Institute for Virology, Essen, Germany.
|
|
| |
| |
|
|
|
